Sotera Health Company (NASDAQ:SHC) Receives $20.43 Average Price Target from Brokerages

Sotera Health Company (NASDAQ:SHC) has received a consensus recommendation of “Moderate Buy” from the eleven ratings firms that are covering the stock, Marketbeat reports. Three research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 1-year price objective among brokers that have covered the stock in the last year is $20.4286.

A number of equities analysts have recently commented on the stock. William Blair assumed coverage on shares of Sotera Health in a research report on Thursday, December 18th. They set an “outperform” rating on the stock. Piper Sandler upgraded Sotera Health from a “neutral” rating to an “overweight” rating and boosted their price target for the company from $17.00 to $24.00 in a report on Friday, January 9th. Citigroup increased their price objective on Sotera Health from $21.00 to $23.00 and gave the stock a “buy” rating in a research note on Tuesday, February 24th. Wells Fargo & Company downgraded Sotera Health to an “overweight” rating in a report on Thursday, January 8th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Sotera Health in a research report on Monday, December 29th.

Sotera Health Stock Up 0.7%

Shares of SHC opened at $13.41 on Monday. The firm has a fifty day moving average price of $17.35 and a 200-day moving average price of $16.75. The company has a current ratio of 2.46, a quick ratio of 2.24 and a debt-to-equity ratio of 3.66. The firm has a market capitalization of $3.81 billion, a P/E ratio of 49.67 and a beta of 1.84. Sotera Health has a 12-month low of $9.53 and a 12-month high of $19.85.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings results on Tuesday, February 24th. The company reported $0.26 EPS for the quarter, topping the consensus estimate of $0.24 by $0.02. The company had revenue of $303.44 million for the quarter, compared to the consensus estimate of $300.68 million. Sotera Health had a net margin of 6.70% and a return on equity of 42.38%. The firm’s revenue was up 4.6% compared to the same quarter last year. During the same quarter last year, the firm posted $0.21 EPS. Sotera Health has set its FY 2026 guidance at 0.930-1.01 EPS. Equities research analysts expect that Sotera Health will post 0.61 earnings per share for the current year.

Insider Activity at Sotera Health

In related news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of Sotera Health stock in a transaction dated Friday, March 6th. The stock was sold at an average price of $15.27, for a total value of $152,700,000.00. Following the completion of the sale, the director directly owned 12,735,301 shares in the company, valued at $194,468,046.27. The trade was a 43.98% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Corporate insiders own 55.12% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Two Seas Capital LP increased its holdings in Sotera Health by 21.1% during the second quarter. Two Seas Capital LP now owns 4,020,867 shares of the company’s stock valued at $44,712,000 after buying an additional 699,731 shares during the period. Voss Capital LP lifted its holdings in Sotera Health by 50.0% during the second quarter. Voss Capital LP now owns 750,000 shares of the company’s stock worth $8,340,000 after buying an additional 250,000 shares during the period. CenterBook Partners LP purchased a new stake in Sotera Health during the third quarter worth $1,228,000. Vanguard Group Inc. boosted its position in Sotera Health by 10.5% during the 3rd quarter. Vanguard Group Inc. now owns 16,471,792 shares of the company’s stock valued at $259,101,000 after acquiring an additional 1,561,282 shares in the last quarter. Finally, Ontario Teachers Pension Plan Board bought a new stake in Sotera Health during the 2nd quarter valued at $1,179,000. 91.03% of the stock is currently owned by institutional investors.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.